Godrej Agrovet Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹2,995 Cr +16.7% YoYSee revenue, profit and what management said. You are viewing Q4 FY26.
GA

Godrej Agrovet Ltd

Q4 FY26Food Products

Godrej Agrovet Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹2,333Cr
+9.3% YoY
−14.2% QoQ
Net profit
₹102Cr
+54.5% YoY
−7.3% QoQ
Margin
6%
−1 pp YoY
−3 pp QoQ
Price₹575
Market cap₹11.2K Cr
P/E23.8

The short version

Astec LifeSciences: Targeting around 15%-20% top-line growth, with CDMO segment expected to grow slightly higher than the enterprise segment; margins to remain intact. Godrej Agrovet aims for early double-digit revenue growth at the consolidated level for FY27.

From Godrej Agrovet Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Astec LifeSciences: Targeting around 15%-20% top-line growth, with CDMO segment expected to grow slightly higher than the enterprise segment; margins to remain intact. CDMO revenue share aimed at 52%-53%+.
  • Animal Nutrition: Strong volume growth continuing, particularly in cattle feed and newly launched products; focusing on volume-driven revenue growth with double-digit growth expected.
  • Oil Palm: Early double-digit volume growth expected, with record area expansion planned; improving oil extraction ratio supports margins.
  • Crop Care: Expected strong recovery from Q2 FY27 onwards, aiming for very high double-digit revenue growth post inventory normalization.

2 more points from Godrej Agrovet Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Godrej Agrovet Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Godrej Agrovet plans capex of around INR 350-400 crores per year going forward.
  • Approximately 75%-80% of capex will be growth-oriented.
  • Around 50% of total capex deployment is targeted toward the Oil Palm business.
  • Specific investments include rolling out a specialty fat refinery starting May FY '27, expected to ramp up in the second half of the year.
  • Investment focus on value-added products in Oil Palm to move the portfolio towards 50%-55% value-added products by FY31.
  • Ongoing strategic restructuring and portfolio reviews to unlock shareholder value over a 4-5 year horizon.

2 more points from Godrej Agrovet Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Food Products

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 1
2Milky Mist Dairy
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Godrej Agrovet Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Relevant insights include: - Astec LifeSciences is witnessing a positive trend with a strong comeback led by CDMO. - The pipeline funnels for Astec CDMO business are looking pretty good, with some good early leads emerging. - The company expects growth around 15-20% in Astec’s CDMO business. - Strategic focus is on increasing value-added portfolio in Crop Care and Oil Palm segments.

2 more points from Godrej Agrovet Ltd's call on order book

Create a free account to keep reading this call

Godrej Agrovet Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Godrej Agrovet Ltd Q4 FY26 results — key figures

Godrej Agrovet Ltd Q4 FY26 reported results vs Q4 FY25, ₹ crore
₹ CrQ4 FY26Q4 FY25YoYQ3 FY26QoQ
Revenue2,3332,134+9.3%2,718-14.2%
Operating profit (EBITDA)139147-5.4%242-42.6%
Operating margin6%7%-1 pp9%-3 pp
Profit before tax13087+49.4%146-11%
Net profit (PAT)10266+54.5%110-7.3%
EPS (₹)5.453.68+48.1%5.97-8.7%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹3.0K Cr, net profit ₹103 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Food Products this season

  • HMA Agro Industries (Q4 FY26)

    The company remains confident about sustaining a 25%-30% growth rate in revenue, supported by increased utilization and higher value-added product contribution…

  • Coastal Corporat (Q4 FY26)

    Total Income from Operations: ₹728.75 Cr . Key investor presentation takeaways from Coastal Corporat's Q4 FY26 investor presentation — and how it ranks against

  • Megastar Foods (Q4 FY26)

    Q4FY26 Revenue from Operations: ₹14,606 lakhs (Page 7) . Key investor presentation takeaways from Megastar Foods's Q4 FY26 investor presentation — and how it ra

  • Mukka Proteins (Q4 FY26)

    Q4 FY26 Revenue from Operations:** ₹381.6 Cr . Key concall takeaways from Mukka Proteins Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Godrej Agrovet Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Godrej Agrovet Ltd Q4 FY26 results?

Astec LifeSciences: Targeting around 15%-20% top-line growth, with CDMO segment expected to grow slightly higher than the enterprise segment; margins to remain intact. Godrej Agrovet aims for early double-digit revenue growth at the consolidated level for FY27.

What is Godrej Agrovet Ltd share price analysis?

Godrej Agrovet Ltd currently shows a neutral. The stock trades at a P/E of 23.8 with a market cap of ₹11,166 Cr. Investors should review the full earnings analysis for detailed insights.

Is Godrej Agrovet Ltd planning capital expenditure?

Godrej Agrovet plans capex of around INR 350-400 crores per year going forward.

Keep Godrej Agrovet Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.